American Century Companies
AURA icon

American Century Companies’s Aura Biosciences AURA Stock Holding History

American Century Companies’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-48,323
Closed -$323K – 2894
2026
Q1 		$323K Buy
48,323
+7,579
+19% +$43.5K ﹤0.01% 2623
2025
Q4 		$222K Buy
40,744
+2,051
+5% +$12.2K ﹤0.01% 2689
2025
Q3 		$239K Sell
38,693
-8,356
-18% -$54.6K ﹤0.01% 2668
2025
Q2 		$295K Sell
47,049
-4,608
-9% -$26.9K ﹤0.01% 2670
2025
Q1 		$303K Buy
51,657
+3,956
+8% +$29.9K ﹤0.01% 2662
2024
Q4 		$392K Buy
47,701
+12,081
+34% +$114K ﹤0.01% 2591
2024
Q3 		$317K Buy
35,620
+19,846
+126% +$170K ﹤0.01% 2623
2024
Q2 		$119K Buy
+15,774
New +$116K ﹤0.01% 2796

Other funds holding AURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies's AURA Position: Q2 2026 in Review

American Century Companies sold out of Aura Biosciences (AURA) in Q2 2026, closing a stake of 48,323 shares — an estimated $323K sold.

American Century Companies first reported a position in AURA in Q2 2024 and held it in 8 quarters. The position peaked at $392K in Q4 2024. 86 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • American Century Companies reported no remaining Aura Biosciences position as of Q2 2026 after selling out during the quarter.
  • American Century Companies sold 48,323 Aura Biosciences shares in Q2 2026, an estimated $323K.
  • American Century Companies first reported a position in Aura Biosciences in Q2 2024 and held it in 8 quarters.
  • American Century Companies's Aura Biosciences position peaked at $392K in Q4 2024.
  • 86 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.